Burden of non‐motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa‐carbidopa intestinal gel

BACKGROUND AND PURPOSE: GLORIA, a registry conducted with 375 advanced Parkinson's disease patients treated with levodopa‐carbidopa intestinal gel (LCIG) for 24 months in routine clinical care, demonstrated significant reductions from baseline in ‘off’ time and ‘on’ time with dyskinesia and imp...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Eur J Neurol
Hlavní autoři: Ray Chaudhuri, K., Antonini, A., Robieson, W. Z., Sanchez‐Soliño, O., Bergmann, L., Poewe, W.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2018
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590168/
https://ncbi.nlm.nih.gov/pubmed/30353942
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.13847
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky